Searched for
BETA DRUGS FUNDING
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analysts
- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analysts
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...13 Jun, 2026, 02.29 PM IST
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...12 Jun, 2026, 12.25 PM IST
- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...08 Jun, 2026, 02.25 PM IST
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...04 Jun, 2026, 09.43 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...01 Jun, 2026, 01.29 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...29 May, 2026, 11.33 PM IST
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...28 May, 2026, 11.04 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...01 May, 2026, 11.01 PM IST
- Beta Drugs raises Rs 117 crore from HealthQuadBeta Drugs secured Rs 117 crore from HealthQuad and other investors to expand globally and boost operational capabilities. The oncology-foc...27 Nov, 2024, 09.34 PM IST
- Ashish Kacholia offloads nearly 4 lakh shares of this smallcap manufacturing companyAce investor Ashish Kacholia made a move on Tuesday by selling a portion of his stake in Ador Welding, a small-cap manufacturer renowned fo...12 Jun, 2024, 12.12 PM IST
- Ashish Kacholia picks up 17% stake in largest homegrown burger chain JumbokingAce investor Ashish Kacholia has picked up a 17.2% stake in homegrown burger chain Jumboking for an undisclosed amount, becoming its second...02 Apr, 2024, 08.59 PM IST
- IT, pharma and telecom top sectoral picks for MFs in AprilFund managers have been sellers in select public sector companies.15 May, 2019, 08.47 AM IST
- Breakthrough using atomic science can treat Alzheimer'sLondon, July 6 (IANS) British researchers have succeeded in revealing the atomic structure of one of the abnormal filaments that lead to Al...06 Jul, 2017, 02.32 PM IST
- AstraZeneca sells ageing beta-blocker to Recordati for $300 mlnAstraZeneca, which retains rights to the beta-blocker outside Europe, will continue to manufacture and ship product to Recordati under a su...22 May, 2017, 01.46 PM IST
- Ex-J&J India head led fight against patentCancer Patients Aid Association is ironically headed by a former country head of a multi-national medical products company.02 Apr, 2013, 04.00 AM IST
- Rel Life Sciences to focus on R&D, for nowThe company is all set to launch fifth biosimilar drug and seeks approvals for clinical trials and stem-cell treatment.13 Jul, 2010, 04.09 AM IST
- Wanbury acquires Spanish drugmaker for Rs 240 crWanbury on Monday said it has agreed to acquire Spanish drugmaker Industria Farmaceutica Cantabri’s branded generic business for Rs 240 cro...17 Oct, 2006, 03.11 AM IST
Load More
